What initial tests should be performed for suspected tuberculosis, including both active and latent infection?

Initial Testing for Tuberculosis

For suspected active TB, chest radiography is the initial imaging test, combined with sputum culture for definitive diagnosis, while for latent TB infection screening, either tuberculin skin test (TST) or interferon-gamma release assay (IGRA) should be used, with IGRA preferred in BCG-vaccinated populations. 1, 2

Suspected Active Tuberculosis

Clinical Assessment First

Suspect active TB based on:

• Constitutional symptoms: Unexplained weight loss, night sweats, fever, prolonged cough (>2-3 weeks), hemoptysis, fatigue 1
• High-risk demographics: Close TB contacts, TB-endemic country exposure, prison/homeless shelter/long-term care facility residence, immunocompromised status 1

Initial Diagnostic Testing Algorithm

Step 1: Chest Radiography (Frontal View Only)

• High sensitivity for detecting active TB manifestations 1
• Classic findings warranting respiratory isolation: Upper lobe or superior-segment lower lobe fibro-cavitary disease, lobar pneumonia with hilar/mediastinal adenopathy 1
• Lateral views do not improve TB detection and are unnecessary 1
• Critical caveat: Immunocompromised patients (especially AIDS with low CD4 counts) may have deceptively normal chest radiographs 1

Step 2: Sputum Collection for Microbiological Confirmation

• When chest radiography confirms clinical suspicion, proceed immediately to respiratory isolation pending sputum cultures 1
• In high TB prevalence settings with available resources, XpertMTB/RIF testing should replace sputum microscopy for initial diagnostic testing 3
• For drug-resistant TB risk (prior TB treatment, drug-resistant TB contacts, high-prevalence countries): XpertMTB/RIF plus sputum mycobacterial cultures with drug susceptibility testing 3

Step 3: CT Chest (Selective Use)

• Indications for CT:
  • Equivocal chest radiographic findings 1
  • High clinical suspicion with normal/near-normal radiograph in immunocompromised patients (AIDS with low CD4, anti-TNF therapy) 1
  • Acid-fast bacilli smear-negative high-risk patients 1
• Advantages: Higher specificity, better visualization of cavitation, tree-in-bud nodules, subtle parenchymal disease, abnormal lymph nodes 1

Latent Tuberculosis Infection (LTBI)

Who to Test

Strong recommendation for systematic testing 2:

• People living with HIV
• Close contacts of pulmonary TB cases (adults and children)
• Patients initiating anti-TNF treatment
• Dialysis patients
• Pre-transplant patients (organ or hematological)
• Silicosis patients

Conditional recommendation for testing 2:

• Prisoners
• Healthcare workers
• Immigrants from high TB burden countries
• Homeless persons
• Illicit drug users

Testing Method Selection

IGRA preferred over TST 2, 4:

• Use IGRA in BCG-vaccinated populations (higher specificity) 5
• Use IGRA when repeat testing may be needed (avoids booster phenomenon)
• TST acceptable when IGRA unavailable, too costly, or logistically burdensome 4
• Both tests have similar sensitivity but IGRA has better specificity in BCG-vaccinated individuals 2, 5

Critical Pre-Testing Requirement

Before testing for LTBI, exclude active TB disease 2, 4:

1. Screen for TB symptoms: Cough, hemoptysis, fever, night sweats, weight loss, chest pain, shortness of breath, fatigue 2
2. Chest radiography: Perform if symptoms present or if active case-finding efforts are underway 2
3. Further investigation: Any individual with TB symptoms or radiological abnormality requires evaluation for active TB before LTBI treatment 2

Important Caveats for LTBI Testing

• Asymptomatic individuals with positive PPD/IGRA: Yield of chest radiography for active TB that would change management is negligible 1
• Neither test distinguishes active from latent TB - clinical and radiographic evaluation mandatory 4
• Quantitative interpretation limitations: Results near cut-points are less reliable; report IGRA results quantitatively 4
• Immunocompromised patients: Both TST and IGRA may have reduced sensitivity; negative results should be interpreted cautiously, especially at low CD4 counts 4, 6

Key Implementation Points

For immunocompromised patients: Lower threshold for CT imaging even with normal chest radiograph, as these patients may have subtle disease not visible on plain films 1

For high-risk contacts of MDR/XDR-TB: Individual risk assessment required regardless of LTBI test results; careful clinical monitoring essential 7

Test selection hierarchy: Prioritize guideline-recommended approaches (chest radiography for active TB, IGRA for LTBI in appropriate populations) over advanced imaging or alternative tests unless specific clinical circumstances warrant deviation 1, 2